Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
SLC7A2 (Solute carrier family 7 member 2) encodes a multi pass transmembrane cationic amino acid transporter, broadly expressed across diverse tissue compartments and detectable in multiple mammalian cell subtypes. This membrane embedded transporter contains substrate recognition transmembrane helical bundles and intracellular cytoplasmic segments that may interact with various cytosolic regulatory partners. Following biosynthesis, newly synthesized SLC7A2 undergoes folding and endomembrane system quality control processing. Mature transporter molecules are anchored to plasma membrane surfaces, while some protein pools remain stored within intracellular vesicular compartments to support transporter maturation, membrane trafficking and physiological protein turnover. Cell surface abundance of SLC7A2 can be dynamically adjusted according to local tissue nutrient transport requirements and adaptive metabolic demands.
Within plasma-membrane microenvironments, SLC7A2 functions as a multi-pass CAT-family cationic amino acid transporter and may interact with regulatory partner molecules without requiring an SLC3 heavy-chain partner for transport activity. Transporter stability, membrane-localized abundance and activity are influenced by surrounding biochemical conditions, which may shape cationic amino acid transport capacity. Perturbations to SLC7A2 structural integrity or expression magnitude may disrupt substrate recognition or translocation and alter measurable readouts from solute-transporter studies. Tissues requiring controlled cationic amino acid uptake depend on properly folded and membrane-localized SLC7A2 to maintain local nutrient-transport homeostasis, and membrane-anchored SLC7A2 may contribute through substrate transport and interactions with intracellular regulatory partners. Genetic sequence alterations within the SLC7A2 coding locus may impair protein folding, substrate binding interfaces, transmembrane region packing and intracellular regulatory-coupling capacity. Closely related solute carrier paralogues may share partial functional similarities, but they cannot fully replicate SLC7A2-specific substrate-selectivity profiles and tissue distribution characteristics. Variations in SLC7A2 protein abundance correspond to cellular adaptive requirements for membrane-mediated amino acid transport responses, rendering this transmembrane transporter a valuable research subject for investigating CAT-family transport biology and membrane nutrient-transport homeostasis. SLC7A2 can sustain cationic amino acid translocation without obligate heteromeric assembly with SLC3 heavy chains. Its characteristic multi pass transmembrane topology and substrate binding pocket architecture distinguish SLC7A2 from many other cell-surface solute transporter molecules, supporting transport-cycle conformational changes and selective substrate recognition. Diminished functional competence of SLC7A2 may reduce cationic amino acid transport capacity and tissue-level nutrient-transport adaptive buffering, underlining its research relevance for solute transporter oriented laboratory investigations.
Fig. 1 Cryo-EM structure of CAT-family amino acid transporter. SLC7A2 belongs to CAT transporters, featuring multi-pass transmembrane helical bundles embedded in lipid bilayer to mediate cationic amino acid transport.1
The biological functions of transmembrane SLC7A2 solute carrier family 7 member 2 protein are focused on cationic amino acid transport, substrate selectivity and transporter regulation:
Creative Biolabs offers purified SLC7A2 membrane protein samples generated under unified preparation workflows, including full-length constructs and isolated domain-truncated variants. Truncated domain fragments cannot recapitulate complete transport-cycle behaviours, whereas full-length constructs suit research focused on cationic amino acid transport and solute-transporter-related functional observation. All batches receive uniform quality screening. Function-oriented observation may only be performed using full-length samples under simulated plasma-membrane-microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length SLC7A2 samples retain intact transmembrane architecture after standardized purification, supporting structural and substrate-interaction analyses under appropriate membrane-mimetic conditions.
Not finding the Membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable SLC7A2 expression cell research models with tunable target-expression levels, applicable to structural observation of multi-pass cationic amino acid transporter membrane protein and research into cationic amino acid transport. Sample evaluation includes sustained target-protein expression detection and preliminary transport-related observation, enabling side-by-side comparison of transport behaviours under differing target-protein abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in cationic amino acid transport efficiency alongside shifting SLC7A2 protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-SLC7A2 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of transporter-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realise multi-dimensional observation of target-protein distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SLC7A2 research:
SLC7A2 is a multi-pass CAT-family transporter that mediates cationic amino acid transport across the plasma membrane without requiring heteromeric assembly with an SLC3 heavy chain.
SLC7A2 expression status may alter cellular cationic amino acid transport capacity and substrate availability, making it an important research target for CAT-family transport and nutrient-homeostasis studies.
No, SLC7A2-associated research reagents from Creative Biolabs are exclusively built for exploring solute-carrier-family-dependent membrane regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length SLC7A2 membrane protein, target-specific recombinant antibodies and tunable-expression cell research models, supporting research on membrane-transport homeostasis and transporter-mediated membrane-partner perception.
Laboratory studies may assess cationic amino acid transport and substrate-dependent transporter activity under defined plasma-membrane conditions.